19
Participants
Start Date
November 15, 2021
Primary Completion Date
February 24, 2023
Study Completion Date
February 24, 2023
CP101
CP101 is an investigational microbiome therapeutic designed to deliver a complete and functional microbiome to durably repair intestinal dysbiosis, which is being evaluated for the prevention of recurrent Clostridioides difficile infection (CDI).
Placebo
Placebo
NYU Langone Medical Center, New York
Mount Sinai Hospital, New York
Weill Cornell Medicine, New York
Montefiore Medical Center, The Bronx
North Shore University Hospital-(Manhasset), Manhasset
Digiovanna Institute For Medical Education and Research, North Massapequa
Central New York Research Corporation, Syracuse
TruCare Internal Medicine & Infectious Diseases, DuBois
Regional GI, Lancaster
Guthrie Clinic, Sayre
University of Pennsylvania, Philadelphia
Christiana Care Health System, Newark
George Washington University School of Medicine and Health, Washington D.C.
Chevy Chase Clinical Research, Chevy Chase
Infectious Diseases Associates of Central Virginia, Lynchburg
Wake Forest Baptist Medical Center, Winston-Salem
University of North Carolina at Chapel Hill, Chapel Hill
Brody School of Medicine at ECU, Greenville
Pinehurst Medical Clinic Inc, Pinehurst
Lowcountry Infectious Diseases PA, Charleston
Main Street Physicians Care, Loris
Emory University Hospital Midtown, Atlanta
Mayo Clinic Jacksonville, Jacksonville
ENCORE Borland-Groover Clinical Research, Jacksonville
University of Florida Health, Gainesville
San Marcus Research Clinic Inc, Miami
Sylvester Comprehensive Cancer Center, Miami
Reliant Medical Research, Miami
Guardian Angel Research, Tampa
St Joseph's Comprehensive Research Institute, Tampa
Theia Clinical Research, LLC, St. Petersburg
Gastroenterology Group of Naples, Naples
MedPharmics LLC, Gulfport
Gastro Health LLC, Cincinnati
William Beaumont Hospital, Farmington Hills
Henry Ford Health System, Novi
Iowa Clinic, Des Moines
Mayo Clinic, Rochester
Mercury Street Medical Group, Butte
NorthShore University HealthSystem, Evanston
Loyola University Medical Center, Maywood
Metro Infectious Disease Consultants, Burr Ridge
St. Charles Clinical Research, LLC, Weldon Spring
Ochsner Clinic Foundation, New Orleans
Digestive Health Associates of Texas, PA, Carrollton
Kelsey Seybold Clinic, Houston
1960 Family Practice P.A., Houston
Southern Star Research Institute LLC, San Antonio
University of Colorado School of Medicine, Aurora
Snake River Research, PLLC, Idaho Falls
University of Utah, Salt Lake City
Mayo Clinic, Phoenix
Facey Medical Foundation, Mission Hills
UCSF, San Francisco
Stanford Healthcare, Stanford
Kaiser Permanente Division of Research, Oakland
Bridgeport Hospital, Bridgeport
Medical Research Center of Connecticut LLC, Hamden
Hartford Hospital, Hartford
Brigham and Womens Hospital, Boston
Women's Medicine Collaborative, Providence
University of Calgary - Calgary Health Region, Calgary
CARe Clinic, Red Deer
Yazdan Medical Corporation, Vancouver
Vancouver Island Health Authority, Victoria
Dalhousie University, Halifax
Saint Joseph's Health Care London, London
University Health Network, Toronto
Lead Sponsor
Finch Research and Development LLC.
INDUSTRY